Evidence map›Paper›PMID 32888124›Full record

ArticleMolecular biology reports2020

High-throughput microRNA profile in adult and pediatric primary glioblastomas: the role of miR-10b-5p and miR-630 in the tumor aggressiveness.

Luiz Guilherme Darrigo Junior, Mirella Baroni, Régia Caroline Peixoto Lira, Silvia Teixeira, Paola Fernanda Fedatto, Vanessa Silva Silveira, Veridiana Kill Suazo, Luciana Chain Veronez, Rodrigo Alexandre Panepucci, David Santos Marco Antônio and 10 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Luiz Guilherme Darrigo JuniorDepartment of Pediatrics, Ribeirao Preto Medical School, University of Sao Paulo - USP, Avenida dos Bandeirantes, 3900, Ribeirao Preto, 14049-900, Brazil.
Mirella BaroniDepartment of Genetics, Ribeirão Preto Medical School, University of Sao Paulo, Ribeirão Preto, SP, Brazil.
Régia Caroline Peixoto LiraDepartment of Pediatrics, Ribeirao Preto Medical School, University of Sao Paulo - USP, Avenida dos Bandeirantes, 3900, Ribeirao Preto, 14049-900, Brazil.
Silvia TeixeiraDepartment of Pediatrics, Ribeirao Preto Medical School, University of Sao Paulo - USP, Avenida dos Bandeirantes, 3900, Ribeirao Preto, 14049-900, Brazil.
Paola Fernanda FedattoDepartment of Pediatrics, Ribeirao Preto Medical School, University of Sao Paulo - USP, Avenida dos Bandeirantes, 3900, Ribeirao Preto, 14049-900, Brazil.
Vanessa Silva SilveiraDepartment of Genetics, Ribeirão Preto Medical School, University of Sao Paulo, Ribeirão Preto, SP, Brazil.
Veridiana Kill SuazoDepartment of Pediatrics, Ribeirao Preto Medical School, University of Sao Paulo - USP, Avenida dos Bandeirantes, 3900, Ribeirao Preto, 14049-900, Brazil.
Luciana Chain VeronezDepartment of Pediatrics, Ribeirao Preto Medical School, University of Sao Paulo - USP, Avenida dos Bandeirantes, 3900, Ribeirao Preto, 14049-900, Brazil.
Rodrigo Alexandre PanepucciHemocentro Foundation, Ribeirão Preto Medical School, University of Sao Paulo, Ribeirão Preto, SP, Brazil.
David Santos Marco AntônioDepartment of Research and Development, Fleury Group, São Paulo, SP, Brazil.
José Andres YunesBoldrini's Children Center, Campinas, SP, Brazil.
Silvia Regina BrandaliseBoldrini's Children Center, Campinas, SP, Brazil.
Simone Dos Santos AguiarState University of Campinas, Campinas, SP, Brazil.
Luciano NederDepartment of Pathology, Ribeirão Preto Medical School, University of Sao Paulo, Ribeirão Preto, SP, Brazil.
Ricardo Santos de OliveiraDivision of Neurosurgery, Department of Surgery, Ribeirão Preto Medical School, University of Sao Paulo, Ribeirão Preto, SP, Brazil.
Hélio Rubens MachadoDivision of Neurosurgery, Department of Surgery, Ribeirão Preto Medical School, University of Sao Paulo, Ribeirão Preto, SP, Brazil.
Carlos Gilberto CarlottiDivision of Neurosurgery, Department of Surgery, Ribeirão Preto Medical School, University of Sao Paulo, Ribeirão Preto, SP, Brazil.
Luiz Gonzaga ToneDepartment of Pediatrics, Ribeirao Preto Medical School, University of Sao Paulo - USP, Avenida dos Bandeirantes, 3900, Ribeirao Preto, 14049-900, Brazil.
Elvis Terci ValeraDepartment of Pediatrics, Ribeirao Preto Medical School, University of Sao Paulo - USP, Avenida dos Bandeirantes, 3900, Ribeirao Preto, 14049-900, Brazil.
Carlos Alberto ScrideliDepartment of Pediatrics, Ribeirao Preto Medical School, University of Sao Paulo - USP, Avenida dos Bandeirantes, 3900, Ribeirao Preto, 14049-900, Brazil. scrideli@fmrp.usp.br.ORCID http://orcid.org/0000-0001-6618-789X

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 471885/2013-4Fundação de Amparo à Pesquisa do Estado de São Paulo 2010/07020-9
6 · The paper itself

Abstract

Glioblastoma (GBM) is the most common primary malignant neoplasm of the central nervous system and, despite the standard therapy; the patients' prognoses remain dismal. The miRNA expression profiles have been associated with patient prognosis, suggesting that they may be helpful for tumor diagnosis and classification as well as predictive of tumor response to treatment. We described the microRNA expression profile of 29 primary GBM samples (9 pediatric GBMs) and 11 non-neoplastic white matter samples as controls (WM) by microarray analysis and we performed functional in vitro assays on these 2 most differentially expressed miRNAs. Hierarchical clustering analysis showed 3 distinct miRNA profiles, two of them in the GBM samples and a group consisting only of cerebral white matter. When adult and pediatric GBMs were compared to WM, 37 human miRNAs were found to be differentially expressed, with miR-10b-5p being the most overexpressed and miR-630 the most underexpressed. The overexpression of miR-630 was associated with reduced cell proliferation and invasion in the U87 GBM cell line, whereas the inhibition of miR-10b-5p reduced cell proliferation and colony formation in the U251 GBM cell line, suggesting that these miRNAs may act as tumor-suppressive and oncogenic miRNAs, respectively. The present study highlights the distinct epigenetic profiling of adult and pediatric GBMs and underscores the biological importance of mir-10b-5p and miR-630 for the pathobiology of these lethal tumors.

Indexed as

Gene Expression ProfilingGene Expression Regulation, NeoplasticAdolescentAdultAgedCell Line, TumorChildChild, PreschoolFemaleGlioblastomaHumansMaleMicroRNAsMiddle AgedRNA, NeoplasmMicroRNAsMIRN10 microRNA, humanMIRN630 microRNA, humanRNA, NeoplasmGlioblastomamiR-10bmiR-630miRNA

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.